BPG is committed to discovery and dissemination of knowledge
Citation
Eksi YE, Sanlioglu AD, Akkaya B, Ozturk BE, Sanlioglu S. Genome engineering and disease modeling via programmable nucleases for insulin gene therapy: Promises of CRISPR/Cas9 technology . World J Stem Cells 2021; 13(6): 485-502 [PMID: 34249224 DOI: 10.4252/wjsc.v13.i6.485]
Please LOGIN to submit a new comment.